Luca Campedel

9PUBLICATIONS
80CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer diagnosisSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 14, 2025
Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study.

Coraline Cheuvart, Paul Gougis, Luca Campedel

|Jul 21, 2025
Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients.

Ilfad Blazevic, Aude Fléchon, Géraldine Pignot

|Jan 14, 2023
Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas.

Omar Alhalabi, Jonathan Thouvenin, Sylvie Négrier

|Sep 26, 2022
Inclusion of patients with chronic kidney disease in randomized phase 3 clinical trials in patients with prostate, breast, lung, and colorectal cancer.

Matthieu Delaye, Adrien Rousseau, Mélanie Try

|Aug 26, 2022
Reversible Tumor Progression Induced by a Dexamethasone Course for Severe COVID-19 during Immune Checkpoint Inhibitor Treatment.

Paul Gougis, Baptiste Abbar, Julie Benzimra

|Aug 05, 2022
Escherichia coli-Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer.

Anne-Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva

Pageof 2

Frequent Collaborators

2 joint publications

Anne-Sophie Hamy

2 joint publications

Baptiste Abbar

1 joint publications

Paul Blanc-Durand

1 joint publications

Marc Espié